The appointment of a new director, who is the current CEO of a diagnostics-focused biotech company, may signal a shift in strategic priorities or an increased focus on in vitro diagnostics.
Filing excerpt
On May 5, 2026, the Board of the Company increased its size from nine to ten members and appointed Pierre Boulud to serve as a director effective as of that date.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
Vendors
Regions named
sec-8kgovernanceChangeGet every 8-K signal for Steris and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Steris this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/48479550-cdb4-46c5-84a8-465599ff170a returns this record as JSON. POST /v1/companies/enrich returns every signal for steris.com.
{
"signal_id": "48479550-cdb4-46c5-84a8-465599ff170a",
"signal_type": "sec-8k",
"signal_subtype": "governanceChange",
"detected_at": "2026-05-12T09:24:50.509+00:00",
"company": {
"name": "Steris",
"domain": "steris.com"
},
"data": {
"detail": "The appointment of a new director, who is the current CEO of a diagnostics-focused biotech company, may signal a shift in strategic priorities or an increased focus on in vitro diagnostics. New board members often influence strategy and review major vendor relationships, creating opportunities for new solution providers.",
"metrics": {
"timeframe": "immediate",
"dollar_context": "Prorated fee for new director Pierre Boulud for the remainder of the Board’s 2025-26 term of office.",
"dollar_millions": 0.076989
},
"summary": "STERIS appoints bioMérieux CEO Pierre Boulud to its Board of Directors, effective May 5, 2026.",
"excerpts": "On May 5, 2026, the Board of the Company increased its size from nine to ten members and appointed Pierre Boulud to serve as a director effective as of that date.",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1757898/000119312526212159/d27562d8k.htm",
"filing_date": "2026-05-07",
"filing_year": 2026,
"sales_relevance": "Governance tools needed",
"signal_category": "esg",
"regions_mentioned": [
"Asia Pacific Region"
],
"vendors_mentioned": [
"Boston Consulting Group"
],
"technologies_mentioned": [
"in vitro diagnostics"
]
}
}
curl https://signals.autobound.ai/v1/signals/48479550-cdb4-46c5-84a8-465599ff170a \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"steris.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.